US Stock MarketDetailed Quotes
SCPH scPharmaceuticals
- 3.620
- -0.120-3.21%
Close Nov 29 13:00 ET
- 3.650
- +0.030+0.83%
Post 17:01 ET
181.15MMarket Cap-1856P/E (TTM)
3.800High3.570Low204.75KVolume3.770Open3.740Pre Close746.98KTurnover0.77%Turnover RatioLossP/E (Static)50.04MShares6.71052wk High5.90P/B95.74MFloat Cap3.07552wk Low--Dividend TTM26.45MShs Float18.170Historical High--Div YieldTTM6.15%Amplitude2.440Historical Low3.648Avg Price1Lot Size
About scPharmaceuticals Company
scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include FUROSCIX, a furosemide injection which is used as parenteral diuretic in treating heart failure and scCeftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.
Company Profile
SymbolSCPH
Company NamescPharmaceuticals
Listing DateNov 17, 2017
Issue Price14.00
Founded2013
CEOMr. John H. Tucker
MarketNASDAQ
Employees136
Fiscal Year Ends12-31
Address25 Burlington Mall Road,Suite 203
CityBurlington
ProvinceMassachusetts
CountryUnited States of America
Zip Code01830
Phone1-617-517-0730
Company Executives
- Name
- Position
- Salary
- John H. Tucker
- Director, President and Chief Executive Officer
- 1.84M
- Rachael Nokes
- Principal Accounting Officer and Chief Financial Officer
- 724.20K
- Jack A. Khattar
- Chairman of the Board
- 227.05K
- Sara M. Bonstein
- Independent Director
- 187.05K
- Minnie V. Baylor-Henry
- Independent Director
- 187.05K
- Dr. Klaus Veitinger, M.D.,PhD
- Independent Director
- 187.05K
- Frederick M. Hudson
- Independent Director
- 197.05K
- Dr. William T. Abraham, M.D.
- Independent Director
- 182.05K
- Mette Kirstine Agger
- Independent Director
- 189.55K
- Leonard D. Schaeffer
- Independent Director
- 184.55K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data